Teamwork and tech take on type 1 diabetes in new trial

NCT ID NCT07097818

Recruiting now Disease control Sponsor: Second Xiangya Hospital of Central South University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a comprehensive management program—including a specialized diabetes team, structured education, peer support, and modern diabetes technology like insulin pumps and continuous glucose monitors—can improve blood sugar control in people with type 1 diabetes. About 400 participants across multiple hospitals will be randomly assigned to either the intensive program or routine care. The main goal is to see if the program lowers HbA1c levels after one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: structured education, peer support, insulin pumps, and continuous glucose monitors
What this could lead to: If successful, this could show that combining specialized care, technology, and peer support helps people with type 1 diabetes achieve better long-term blood sugar control.
What could go wrong: This is a behavioral intervention trial, not a new drug or cure. Results may vary across hospitals, and the benefits might not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

Department of Endocrinology and Metabolism, Institute of Endocrinology, The First Affiliated Hospital of China Medical University
NOT_YET_RECRUITING

Shenyang, Liaoning, China
Department of Endocrinology and Metabolism, Laboratory of Diabetes and metabolism research, West China Hospital, Sichuan University
NOT_YET_RECRUITING

Chengdu, Sichuan, China
Department of Endocrinology and Metabolism, Peking University People's Hospital
NOT_YET_RECRUITING

Beijing, Beijing Municipality, China
Department of Endocrinology, Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health
NOT_YET_RECRUITING

Hangzhou, Zhejiang, China
Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University
NOT_YET_RECRUITING

Quanzhou, Fujian, China
Department of Endocrinology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University
NOT_YET_RECRUITING

Shenzhen, Guangdong, China
Department of Endocrinology, Zhongnan Hospital of Wuhan University
NOT_YET_RECRUITING

Wuhan, Hubei, China
Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology
RECRUITING

Luoyang, Henan, 471003, China
Institute of Metabolism and Endocrinology, Second Xiangya Hospital of Centra South University
RECRUITING

Changsha, Hunan, 410011, China
Second Department of Endocrinology and Metabolism, Tangshan Gongren Hospital
NOT_YET_RECRUITING

Tangshan, Hebei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.